Oric Pharmaceuticals (ORIC)

• Market cap: $1.16B
• 1 day: 0.42%
• 5 days: 2.59%
• 1 month: -11.62%
• 3 months: 18.34%
• 6 months: 98.83%
• Year to date: 43.7%
• 1 year: 19.9%
• 5 years: -65%
• 10 years: -53.94%
• Sector: Healthcare
• Industry: Biotechnology

About: ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

Employees: 106